Search for: "Burch v. Burch"
Results 1 - 20
of 142
Sort by Relevance
|
Sort by Date
25 Mar 2024, 6:00 am
"Because OCA created an ambiguity, it is resolved against the agency, and the petition is deemed timely (see Matter of Burch v New York City Health and Hosps. [read post]
25 Mar 2024, 6:00 am
"Because OCA created an ambiguity, it is resolved against the agency, and the petition is deemed timely (see Matter of Burch v New York City Health and Hosps. [read post]
5 Mar 2024, 12:50 pm
On March 6, the Third Circuit Court of Appeals will hear oral arguments in the whistleblower retaliation case Lindsey Gulden and Damian Burch v. [read post]
17 Jan 2024, 6:38 am
Burch v. [read post]
17 Aug 2023, 11:09 am
In the case Lindsey Gulden and Damian Burch v. [read post]
1 Jun 2023, 6:00 am
In Reed v. [read post]
11 May 2023, 1:11 pm
On April 19, 2023, in Gulden v. [read post]
13 Mar 2023, 6:14 am
Burch, 169 F.3d 666, 669 (10th Cir. 1999). [read post]
Virtual Symposium on the Contracts Scholarship of Mel Eisenberg, Part V: Introducing the Second Week
6 Mar 2023, 4:17 am
Mark Gergen is the Robert and Joann Burch D.P.... [read post]
12 Jul 2022, 11:11 am
Burch, 494 U. [read post]
11 May 2022, 8:51 pm
By Alissa Del Riego (May 11, 2022, 5:56 PM EDT) Alissa Del RiegoI started my law career at a large multinational law firm representing corporate clients, and officers and directors defending shareholder derivative claims. [read post]
6 Dec 2021, 10:56 am
Rosen’s article Katcoff v. [read post]
20 Nov 2021, 5:54 am
From Burch v. [read post]
16 Nov 2021, 12:00 am
Resources Legal Cases Riley v. [read post]
12 Apr 2021, 11:16 am
In State of Michigan v. [read post]
8 Mar 2021, 2:27 pm
The Law In a landmark ruling in Riley v. [read post]
6 Jul 2020, 12:35 pm
Civil litigation — Maryland Consumer Debt Collection Act — Fee collection Walter B. [read post]
23 Feb 2020, 9:54 am
In opposition, he appears to rely upon Elizabeth Chamblee Burch, a professor at the University of Georgia School of Law for the view that because the initial pivotal clinical trials for regulatory approvals take place in limited populations, litigation “serves as a stopgap for identifying rare adverse outcomes that could crop up when several hundreds of millions of people are exposed to those products over longer [read post]
12 Aug 2019, 12:19 pm
V. [read post]
2 May 2019, 10:44 am
”) [7] See Elizabeth Chamblee Burch & Margaret S. [read post]
